Allogene Therapeutics Inc (ALLO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | N/A | -54.663 | -24.75 | -25.721 | -22.679 | -35.85 | -44.833 |
Return on Equity (%) | 200 | -60.158 | -27.713 | -29.289 | -25.752 | -42.045 | -55.558 |
Return on Invested Capital (%) | 200 | -81.109 | -39.006 | -36.507 | -36.88 | -60.761 | -59.019 |
Operating Margin (%) | N/A | N/A | N/A | N/A | -667.736 | -136885.597 | -344489.474 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -667.736 | -136885.597 | -344489.474 |
Book Value Per Share | N/A | 5.782 | 5.061 | 7.686 | 6.425 | 4.61 | 3.044 |
Earnings Per Share | N/A | -1.741 | -1.485 | -1.781 | -1.802 | -2.303 | -1.945 |
Cash Per Share | N/A | 0.761 | 1.409 | 1.305 | 1.215 | 0.429 | 0.494 |
Working Capital Per Share | N/A | 3.61 | 4.116 | 5.345 | 2.967 | 3.284 | 2.508 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.27 | 0.002 | 0.001 |
EBIT Per Share | N/A | -1.742 | -1.488 | -1.781 | -1.802 | -2.303 | -1.945 |
EBITDA Per Share | N/A | -1.742 | -1.488 | -1.781 | -1.802 | -2.303 | -1.945 |
Free Cash Flow Per Share | N/A | -1.727 | -1.119 | -1.366 | -1.725 | -2.366 | -2.02 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 26,25M | 121,48M | 124,27M | 140,47M | 142,62M | 144,44M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 144,44M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -189815.385 | N/A | N/A | N/A | -295454.545 | N/A | N/A |
Net Profit Margin (%) | N/A | -189815.385 | N/A | N/A | N/A | -295454.545 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 399,43M |
Ratio cours/bénéfice | -1,22 |
Ratio prix/ventes | 3,8k |
Ratio prix/liquidités | 4,79 |
Ratio prix/valeur comptable | 0,78 |
Rendement de dividende | - |
Actions en circulation | 209,67M |
Volume moyen (1 semaine) | 2,86M |
Volume moyen (1 mois) | 2,47M |
Variation sur 52 semaines | -35,42% |
Plus haut sur 52 semaines | 5,775 |
Plus bas sur 52 semaines | 1,83 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales